Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenosine triphosphate (ATP) secretion refers to the active process by which cells export intracellular ATP into the extracellular space. This process is not itself a single molecular target but rather a cellular event involving multiple proteins and pathways. Extracellular ATP acts as an important signaling molecule in various physiological contexts including neurotransmission, immune responses, and inflammation. Mechanistically, ATP can be secreted via several routes, such as exocytosis of secretory vesicles containing high concentrations of ATP—mediated by the vesicular nucleotide transporter (VNUT)—or through plasma membrane channels like pannexin 1 during processes such as immunogenic cell death[6][7]. During cancer therapy-induced immunogenic cell death, for example, dying tumor cells secrete large amounts of ATP via mechanisms requiring autophagy-related lysosomal exocytosis and caspase-dependent activation of both Rho-associated kinase 1 (ROCK1) and myosin II-driven blebbing. Pannexin 1 channels are also involved in this regulated release pathway[6]. Extracellularly released ATP functions as a danger signal, activating purinergic receptors on immune cells to stimulate anti-tumor immunity or modulate inflammation. Dysregulation or excessive extracellular accumulation can contribute to pathological conditions such as chronic inflammation or neuropathic pain. Because "ATP secretion" describes a biological process rather than an individual protein or receptor target—and involves multiple molecules—it is not considered an actionable therapeutic target itself but rather an outcome influenced by targeting specific transporters/channels or upstream regulators involved in its control[6][7].
Inhibition of vesicular nucleotide transporter to reduce vesicular/extracellular ATP[7] Induction of immunogenic cell death leading to caspase-dependent and pannexin 1 channel-mediated ATP secretion[6]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine triphosphate secretion (ATP secretion).